Close Menu
    Facebook LinkedIn YouTube WhatsApp X (Twitter) Pinterest
    Trending
    • New York Mets and Novig prediction market partnership explained
    • Today’s NYT Mini Crossword Answers for Saturday, Aug. 1
    • AI firms must answer for rogue bots, says Hugging Face boss
    • Prompt Engineering Is Solved—Prompt Management Isn’t
    • Samsung’s chip workers are jumping ship to rival SK Hynix 
    • Tactile-Based Robot Centering as a Capability for Dexterous Manipulation
    • Dog tracker uses Starlink for lost pets when cell signal drops
    • Sniffing chocolate for ‘leg day’ at the gym is the latest craze. Here’s the reality
    Facebook LinkedIn WhatsApp
    Times FeaturedTimes Featured
    Sunday, August 2
    • Home
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    • More
      • AI
      • Robotics
      • Industries
      • Global
    Times FeaturedTimes Featured
    Home»Tech Innovation»World’s first chlamydia vaccine approved for koalas
    Tech Innovation

    World’s first chlamydia vaccine approved for koalas

    Editor Times FeaturedBy Editor Times FeaturedSeptember 10, 2025No Comments5 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email WhatsApp Copy Link


    Australia’s embattled koalas have been given some excellent news for as soon as, with the approval of the world’s first chlamydia vaccine for the marsupial. Greater than a decade within the making, the vaccine will defend koalas from the widespread illness that causes painful urinary tract infections, infertility, blindness and loss of life.

    Developed by College of the Sunshine Coast (UniSC) scientists, with the assist of world establishments together with the College of Saskatchewan’s Vaccine and Infectious Illness Group (VIDO), the Worldwide Vaccine Institute, the College of British Colombia and Dalhousie College, with funding from the Invoice and Melinda Gates Basis, the vaccine is a milestone within the efforts to save lots of susceptible koalas.

    Microbiologist Peter Timms has led the cost in growing the primary koala chlamydia vaccination

    College of the Sunshine Coast

    “UniSC knew a single-dose vaccine – with out the necessity for a booster – was the reply to lowering the speedy, devastating unfold of this illness, which accounts for as a lot as half of koala deaths throughout wild populations,” stated Professor of Microbiology Peter Timms, who spearheaded the analysis. “Some particular person wild colonies, the place an infection price could be as excessive as 70%, are edging nearer to extinction each day.

    “We have been decided to do the exhausting yards to maneuver from analysis to this very important subsequent stage – a high-quality, veterinary-approved product that may now be utilized in wildlife hospitals, veterinary clinics and within the area to guard the nation’s most at-risk koalas,” he added.

    The longer term for koalas is trying higher

    The final IUCN Crimson Record analysis for the koala Phascolarctos cinereus was greater than 10 years in the past, in 2014. Since then, the species has confronted many challenges accelerating their inhabitants loss in Australia: habitat clearance, illness and wildfires. In the summertime of 2019, more than 6,200 koalas in New South Wales – 15% of the state’s inhabitants – are thought to have perished within the devastating fires. There fires are anticipated to change into extra frequent and extra excessive within the local weather disaster.

    The vaccine, manufactured by Tréidlia Biovet and authorized by Australia’s veterinary drugs regulators, is a serious transfer in serving to to maintain these animals away from the brink of extinction and stop pointless struggling via this illness. Till now, the one intervention has been antibiotics, which in flip upset the koala’s delicate digestive tract – one fine-tuned to solely eat eucalyptus leaves. This disruption has led to koalas ravenous and, in some circumstances, dying because of this. And antibiotics do not defend koalas from repeat infections.

    Sam Phillips (left) and Timms have spent more than a decade researching and trialing this landmark vaccine
    Sam Phillips (left) and Timms have spent greater than a decade researching and trialing this landmark vaccine

    College of the Sunshine Coast

    The trail to the vaccine additionally included the most important and longest research of untamed koalas, additionally led by UniSC. Over the span of a decade, 680 koalas have been tracked, and 5 vaccine trials noticed 165 animals given the shot. This finally confirmed the vaccine’s security and efficacy.

    Over a decade, 680 koalas have been tracked, with 5 vaccine trials involving 165 koalas.

    “This research discovered it diminished the chance of koalas growing signs of chlamydia throughout breeding age and decreased mortality from the illness in wild populations by no less than 65%,” stated Sam Phillips, a UniSC researcher who led the intensive trials. “The vaccine has been trialed on a whole lot of untamed koalas, others in captivity and wildlife hospitals, and over a number of generations.

    “It’s primarily based on Chlamydia pecorum’s main outer membrane protein (MOMP), and affords three ranges of safety – lowering an infection, stopping development to scientific illness, and, in some circumstances, reversing current signs,” Phillips added.

    The vaccine has six parts, designed to supply widespread safety for the native wildlife no matter the place they’re situated throughout Australia. Importantly, it is a minimally invasive intervention, with a person koala solely needing one jab for all times.

    A koala undergoing a medical examination. In some populations, up to 90% of individuals have chlamydia infections
    A koala present process a medical examination. In some populations, as much as 90% of people have chlamydia infections

    College of the Sunshine Coast

    “Three [of the six components] are the proteins of chlamydia, designed to cowl the completely different strains of chlamydia circulating in several elements of the nation,” Timms stated. “There are additionally three elements to the adjuvant, which we’re more than happy to have designed as a single-shot adjuvant. Many vaccines require a booster, however we’ve purposely developed a vaccine that solely requires one shot, and for a wild animal like koalas, that’s what you actually need.”

    Nonetheless, the vaccine’s approval is simply step one. Extra funding can be required to roll out vaccination packages to populations across the nation. And administering jabs to wildlife shouldn’t be as simple as taking a pet to the vet – koalas sleep up to 20 hours a day, hidden excessive in tree canopies the place they continue to be well-camouflaged. As a result of they’re most energetic at night time, are solitary exterior of mating, and are unfold over huge distances, getting the drugs to the animals presents a number of logistical challenges.

    “Each contribution will go in direction of vaccinating at-risk koalas and to assist reverse the alarming impacts of this illness,” Timms stated. “We’re additionally persevering with to refine the product and conduct ongoing analysis to make sure the vaccine’s long-term success.”   

    The trial analysis was printed in 2024 within the Nature Partner Journals’ Vaccines.

    Supply: University of the Sunshine Coast





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editor Times Featured
    • Website

    Related Posts

    Dog tracker uses Starlink for lost pets when cell signal drops

    July 26, 2026

    Weight loss drug effectiveness and long term maintenance

    July 16, 2026

    Portable bunkers ready for disaster survival

    July 6, 2026

    Electronic nose detects spoiled food in your fridge

    June 26, 2026

    Personal UV tracking for better sun protection

    June 16, 2026

    Toyota Corolla GRMN: Nürburgring-proven hot hatch unveiled

    June 6, 2026

    Comments are closed.

    Editors Picks

    New York Mets and Novig prediction market partnership explained

    August 2, 2026

    Today’s NYT Mini Crossword Answers for Saturday, Aug. 1

    August 1, 2026

    AI firms must answer for rogue bots, says Hugging Face boss

    July 31, 2026

    Prompt Engineering Is Solved—Prompt Management Isn’t

    July 29, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    About Us
    About Us

    Welcome to Times Featured, an AI-driven entrepreneurship growth engine that is transforming the future of work, bridging the digital divide and encouraging younger community inclusion in the 4th Industrial Revolution, and nurturing new market leaders.

    Empowering the growth of profiles, leaders, entrepreneurs businesses, and startups on international landscape.

    Asia-Middle East-Europe-North America-Australia-Africa

    Facebook LinkedIn WhatsApp
    Featured Picks

    Gear News of the Week: Kia Shows off the EV2, and Fujifilm Debuts New Instax Cameras

    January 17, 2026

    What AI-native means for startups in 2026, and why it is not just for big tech

    January 2, 2026

    The Best Mobile Gaming Controllers for iPhone and Android (2026)

    May 8, 2026
    Categories
    • Founders
    • Startups
    • Technology
    • Profiles
    • Entrepreneurs
    • Leaders
    • Students
    • VC Funds
    Copyright © 2024 Timesfeatured.com IP Limited. All Rights.
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us

    Type above and press Enter to search. Press Esc to cancel.